Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096con1.1 | T2D treatment – should we wait for approved medication? | IMPE2023

Clinicians should muster the courage to use off-label medications when treating young patients with type 2 diabetes.

Curran Jacqueline

The medical world has been undertreating youth onset type 2 diabetes for decades. With the number of youths affected by this devastating disease increasing worldwide there is no room in modern medicine for clinical inertia. Intensified therapy to treat-to-target rather than treat-to-failure is best practice. Clinicians caring for youth affected by type 2 diabetes need to be prepared to muster the courage and ask for early access to off-label medications....

impe0096fc11.1 | Diabetes and Insulin 1 | IMPE2023

Adolescents with type 2 diabetes experience significant diabetes-specific distress, poor emotional wellbeing and have unmet needs hindering optimal diabetes care

Spajic Dana , Subramani Gitanjali , Curran Jacqueline , Speight Jane , Shah Mark , James Radhika , Thus Maree , Pena Alexia

Introduction: Type 2 diabetes (T2D) is increasing among adolescents and is associated with suboptimal mental health. Diabetes-specific distress (DD) is common in adolescents with Type 1 diabetes but there is limited data in adolescents with T2D. Additionally, data in relation to how clinicians can better support the emotional wellbeing and engage adolescents with T2D is limited to Indigenous adolescents.Aims: To evaluate...